血清胰高血糖素样肽-1与糖尿病颈动脉粥样硬化关系及风险列线图的建立OA
The Relationship between Serum Glucagon-Like Peptide-1 and Diabetic Carotid Atherosclerosis and the Establishment of A Risk Nomogram
目的:探究2型糖尿病患者血清中的胰高血糖素样肽-1(GLP-1)和颈动脉粥样硬化之间是否存在联系并构建出一个能预测2型糖尿病合并颈动脉粥样硬化风险的列线图模型.方法:选取2023年12月—2025年1月于上海市徐汇区大华医院内分泌科住院治疗的120例2型糖尿病患者进行回顾性分析.根据住院期间接受的颈部血管彩色多普勒超声检查结果,将其分为两组:存在颈动脉粥样硬化斑块者归入颈动脉粥样硬化组,未见明显斑块形成者则纳入单纯2型糖尿病组.比较两组一般临床资料及生化指标,采用logistic回归分析颈动脉粥样硬化的影响因素,同步构建风险预测列线图模型.采用受试者工作特征(ROC)曲线评估模型的判别效能,以曲线下面积(AUC)量化其准确性;并通过决策曲线分析(DCA)评估模型在不同阈值概率下的净获益,判断其临床应用价值.结果:纳入研究的120例T2DM患者,其中合并颈动脉粥样硬化患者69例(57.5%),单纯2型糖尿病患者51例(42.5%).组间比较显示,两组年龄、性别、身高、胰高血糖素样肽-1(GLP-1)、收缩压、空腹血糖(FPG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、糖化血红蛋白(HbA1c)指标,差异有统计学意义(P<0.05).经多因素logistic回归分析,GLP-1水平降低、空腹血糖升高及总胆固醇升高均为2型糖尿病合并颈动脉粥样硬化的独立危险因素(P<0.05).基于上述具有统计学意义的变量,构建列线图预测模型.该模型ROC曲线下面积为0.91(95%CI:0.86~0.96),表明其判别能力良好;Hosmer-Lemeshow检验P值为0.323,提示模型具有良好校准度与稳定性.决策曲线分析(DCA)结果显示,在广泛阈值概率范围内模型均呈现正向净获益,表明其具备潜在的临床应用价值.结论:GLP-1水平降低、空腹血糖水平升高以及总胆固醇水平升高均为2型糖尿病患者并发颈动脉粥样硬化的独立危险因素,基于上述变量构建的预测模型对该疾病组合具有良好的判别效能与临床应用潜力.
Objective:To explore whether there is a connection between glucagon-like peptide-1(GLP-1)in the serum of patients with type 2 diabetes and carotid atherosclerosis,and to construct a nomogram model that can predict the risk of type 2 diabetes complicated with carotid atherosclerosis.Method:A retrospective study was conducted on 120 patients with type 2 diabetes who were hospitalized in the Department of Endocrinology of Dahua Hospital,Xuhui District,Shanghai from December 2023 to January 2025.Based on the results of the color Doppler ultrasound examination of the cervical vessels received during hospitalization,they were divided into two groups:those with carotid atherosclerotic plaques were classified into the carotid atherosclerosis group,while those without obvious plaque formation were included in the simple type 2 diabetes group.The general clinical data and biochemical indicators of the two groups were compared.logistic regression was used to analyze the influencing factors of carotid atherosclerosis,and a risk prediction nomogram model was constructed simultaneously.The discriminative efficacy of the model was evaluated by the receiver operating characteristic(ROC)curve,and its accuracy was quantified by the area under the curve(AUC).And the net benefits of the model under different threshold probabilities were evaluated through decision curve analysis(DCA)to determine its clinical application value.Result:Among the 120 T2DM patients included in the study,69 cases(57.5%)were complicated with carotid atherosclerosis and 51 cases(42.5%)were patients with simple type 2 diabetes.Intergroup comparisons showed that there were statistically significant differences in age,gender,height,glucagon-like peptide-1(GLP-1),systolic blood pressure,fasting plasma glucose(FPG),total cholesterol(TC),low-density lipoprotein cholesterol(LDL-C),and glycated hemoglobin(HbA1c)between the two groups(P<0.05).Multivariate logistic regression analysis showed that decreased GLP-1 level,elevated fasting blood glucose and elevated total cholesterol were all independent risk factors for type 2 diabetes mellitus complicated with carotid atherosclerosis(P<0.05).Based on the above statistically significant variables,a nomogram prediction model is constructed.The area under the ROC curve of this model was 0.91(95%CI:0.86~0.96),indicating that its discriminative ability was good.The P value of the Hosmer-Lemeshow test was 0.323,suggesting that the model had good calibration and stability.The results of decision curve analysis(DCA)show that the model presents positive net benefits within a wide range of threshold probabilities,indicating that it has potential clinical application value.Conclusion:Decreased GLP-1 level,elevated fasting blood glucose level and elevated total cholesterol level are all independent risk factors for carotid atherosclerosis in patients with type 2 diabetes,and the differences are statistically significant(P<0.05).The predictive model constructed based on the above variables has good discriminative efficacy and clinical application potential for this disease combination.
陈闪闪;王奕;孟祥英;魏祎
上海市徐汇区大华医院 上海 200237上海市徐汇区大华医院 上海 200237上海市徐汇区大华医院 上海 200237新乡医学院第三附属医院
血糖胰高血糖素样肽-12型糖尿病颈动脉粥样硬化列线图模型
Glucagon-like peptide-1Type 2 diabetes mellitusCarotid atherosclerosisNomogram model
《中外医学研究》 2026 (5)
17-21,5
评论